New Rhein Healthcare Investors
Venture Capital
Active
Philadelphia, United States
9
17M
8
0.69
4
0.11
3
- Stages of investment
- Areas of investment
Summary
In 2010 was created New Rhein Healthcare, which is appeared as VC. The venture was found in North America in United States. The main office of represented VC is situated in the Chicago.
Among the most popular portfolio startups of the fund, we may highlight Neuraptive Therapeutics, Biocartis, Chase Pharmaceuticals. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Medical Device, Medical.
The overall number of key employees were 3.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the New Rhein Healthcare, startups are often financed by Johnson & Johnson Development Corporation, Debiopharm Group, Aescap Venture. The meaningful sponsors for the fund in investment in the same round are Valiance Asset Management, RMM, Philips Venture Capital Fund. In the next rounds fund is usually obtained by PMV Tina Fund, Johnson & Johnson Development Corporation, Wellcome Trust.
The top amount of exits for fund were in 2016. The real fund results show that this VC is 30 percentage points more often commits exit comparing to other companies. The high activity for fund was in 2018. Comparing to the other companies, this New Rhein Healthcare performs on 21 percentage points more the average number of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year.
Investor highlights
- Industry focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 4
- Exits
- 3
- Rounds per year
- 0.69
- Follow on index
- 0.11
- Investments by industry
- Biotechnology (6)
- Medical (5)
- Health Care (4)
- Therapeutics (3)
- Commercial (2) Show 5 more
- Investments by region
-
- United States (5)
- Israel (2)
- Switzerland (1)
- Belgium (1)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 82M
- Group Appearance index
- 0.56
- Avg. company exit year
- 9
- Avg. multiplicator
- 4.36
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Corsair Pharma | 20 Sep 2023 | Early Stage Venture | 23M | United States, California, Sunnyvale |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.